License Premium Biosimilars Built for Commercial Success
Phenotypeca offers licensing opportunities for a growing pipeline of high-value biosimilars. Current assets include:
- Semaglutide for obesity and diabetes
- Sargramostim for stockpiling against acute radiation syndrome
- Recombinant Human Albumin for plasma expansion
Each product is backed by our proprietary QTL optimised strain, enabling partners to scale production, reduce cost, and secure strong IP positions. We support both technology transfer to in-house teams or third-party manufacture and supply arrangements.
Our goal is to enable partners to gain substantial and rapid market share through access to high-quality, scalable biosimilars with robust IP protection and low manufacturing costs.
Semaglutide
A GLP-1 analogue addressing global demand in obesity and diabetes care.
- Semi-recombinant manufacture
- Optimised for high-yield, low-cost production
- Patent-protected strain
- Batch consistency matching reference standards
- Scalable to high-volume market needs
Sargramostim
A recombinant GM-CSF immunomodulator for national stockpiling in the event of nuclear accident or attack.
- High-quality product for efficient receptor binding
- Suitable for scaled manufacture
- Consistent batch quality
- High yield production strains for low production cost
Recombinant Albumin
A premium, animal-free alternative for use in plasma expansion.
- High-quality Saccharomyces cerevisiae expression platform
- Avoids critical albumin modification seen in Pichia pastoris and rice-derived albumins
- Suitable for large-scale manufacture
- Low cost and high consistency
- Protectable process with licensing-ready strains
Why License from Phenotypeca?
- QTL Advantage: Proprietary platform delivers bioequivalent performance and commercial scalability
- Proven IP Generation: Patents to protect strains and prevent competitor entry
- Manufacturing Ready: Strains optimised for scale-up while simplifying and downstream processing development
- Trusted by Partners: Including the Bill and Melinda Gates Foundation
- Seamless Technology Transfer: We support licensees with data packs, strain onboarding, and offer manufacture and supply options
We support our licensees with data access, technical packs, and strain onboarding for in-house use.
